Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes
Open Access
Abstract
Previous studies have linked elevated plasma trimethylamine N-oxide (TMAO) levels to poor renal function. The relationship between TMAO and chronic kidney disease (CKD) in type 2 diabetes (T2D) is still unclear. We investigated the association between plasma TMAO levels and CKD in patients with T2D. A cross-sectional study of 133 patients with T2D with or without CKD has been conducted. Blood biomarkers of kidney function, diabetes, and inflammation were assessed in the study participants. Plasma TMAO levels were quantified using UPLC-MS/MS. People with T2D and CKD exhibited significantly higher plasma TMAO levels [10.16 (5.86–17.45) µmol/L] than those without CKD [4.69 (2.62–7.76) µmol/L] (p = 0.002). Participants in the highest quartile of TMAO levels (>8.38 µmol/L) presented relatively elevated serum creatinine levels and a higher number of people with CKD than those in the lower quartiles. TMAO levels were significantly correlated with kidney function biomarkers, including estimated glomerular filtration rate and urinary albumin to creatinine ratio. The association between TMAO and CKD was evident (p < 0.0001) and remained significant after adjusting for risk factors of kidney disease, including age, gender, body mass index, duration of diabetes, and smoking. These findings suggest the association between plasma TMAO and CKD in patients with T2D.Keywords
This publication has 40 references indexed in Scilit:
- Alterations of intestinal barrier and microbiota in chronic kidney diseaseNephrology Dialysis Transplantation, 2014
- Cardiovascular Complications of Diabetic Kidney DiseaseAdvances in Chronic Kidney Disease, 2014
- Diabetic nephropathy and inflammationWorld Journal of Diabetes, 2014
- Microinflammation in the pathogenesis of diabetic nephropathyJournal of Diabetes Investigation, 2013
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2American Journal of Kidney Diseases, 2010
- Gut Microbiota in Health and DiseasePhysiological Reviews, 2010
- Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in DiabetesJournal of the American Society of Nephrology, 2009
- Diabetic nephropathy: Important pathophysiologic mechanismsDiabetes Research and Clinical Practice, 2008
- Pharmacokinetics of triethylamine and triethylamine-N-oxide in manToxicology and Applied Pharmacology, 1989